LadRx Corp (LADX)

Latest Insider Confidence Score

2025Q4

50.0
Bearish

Company insider confidence (by quarter)

2003Q3 2025Q4

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Kriegsman Steven A CEO 6,668,038 Aug 13, 2020
Patterson Scott Bradford 10% Owner 4,577,605 Dec 12, 2013
Cytrx Corp 10% Owner 3,093,881 Jul 2, 2010
Ignarro Louis Director 1,300,785 Aug 13, 2020
Brien Earl W — 740,247 Aug 20, 2020

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 15, 2024 Jan 29, 2024 Caldwell Joel K Director Neutral 52.5 - 0.00% ✗ -
Jan 15, 2024 Jan 29, 2024 Claiborne Cary J Director Neutral 52.5 - 0.00% ✗ -
Jan 15, 2024 Jan 29, 2024 Simpson Jennifer K. Director Neutral 52.5 - 0.00% ✗ -
Jan 15, 2024 Jan 29, 2024 CALOZ JOHN Y CFO Neutral 52.5 - 0.00% ✗ -
Jan 15, 2024 Jan 29, 2024 Snowdy Stephen CEO Neutral 52.5 - 0.00% ✗ -
Jul 28, 2022 Claiborne Cary J Director Neutral 52.5 - 0.00% ✗ -
Jan 10, 2022 Jan 12, 2022 Snowdy Stephen CEO Neutral 52.5 - 0.00% ✗ -
Jan 12, 2022 Snowdy Stephen CEO Neutral 52.5 - 0.00% ✗ -
Dec 15, 2021 Jan 11, 2022 Simpson Jennifer K. Director Neutral 52.5 - 0.00% ✗ -
Dec 15, 2021 Dec 17, 2021 Simpson Jennifer K. Director Neutral 90.0 +25,000 100.00% ✗ -
Aug 11, 2021 Simpson Jennifer K. Director Neutral 52.5 - 0.00% ✗ -
Aug 14, 2020 Aug 20, 2020 Brien Earl W Director Neutral 52.5 - 0.00% ✗ -
Aug 7, 2020 Aug 13, 2020 KRIEGSMAN STEVEN A CEO Sell 20.0 -1,164,179 -24.09% ✗ $780K
Aug 7, 2020 Aug 13, 2020 IGNARRO LOUIS Director Sell 22.5 -271,642 -31.14% ✗ $182K
Aug 7, 2020 Aug 13, 2020 Caldwell Joel K Director Sell 22.5 -174,627 -34.24% ✗ $117K
Dec 13, 2019 Dec 17, 2019 KRIEGSMAN STEVEN A CEO Neutral 52.5 - 0.00% ✗ -
Dec 13, 2019 Dec 17, 2019 IGNARRO LOUIS Director Neutral 52.5 - 0.00% ✗ -
Dec 13, 2019 Dec 17, 2019 CALOZ JOHN Y CFO Neutral 52.5 - 0.00% ✗ -
Dec 13, 2019 Dec 17, 2019 Caldwell Joel K Director Neutral 52.5 - 0.00% ✗ -
Dec 13, 2019 Dec 17, 2019 Brien Earl W Director Neutral 52.5 - 0.00% ✗ -
May 21, 2018 Curtis Eric COO Neutral 52.5 - 0.00% ✗ -
Dec 15, 2017 Jan 2, 2018 Kratz Felix President Neutral 52.5 - 0.00% ✗ -
Jan 2, 2018 Kratz Felix President Neutral 52.5 - 0.00% ✗ -
Dec 15, 2017 Dec 19, 2017 IGNARRO LOUIS Director Neutral 52.5 - 0.00% ✗ -
Dec 15, 2017 Dec 19, 2017 CALOZ JOHN Y CFO Neutral 52.5 - 0.00% ✗ -
Dec 15, 2017 Dec 19, 2017 Caldwell Joel K Director Neutral 52.5 - 0.00% ✗ -
Dec 15, 2017 Dec 19, 2017 Brien Earl W Director Neutral 52.5 - 0.00% ✗ -
Dec 15, 2017 Dec 19, 2017 KRIEGSMAN STEVEN A CEO Neutral 90.0 +387,597 100.00% ✗ -
Jul 12, 2017 Sep 6, 2017 Caldwell Joel K Director Neutral 52.5 - 0.00% ✗ -
Sep 6, 2017 Caldwell Joel K Director Neutral 52.5 - 0.00% ✗ -
Jun 20, 2017 Chawla Shanta M.D. Senior VP-Drug Development Neutral 52.5 - 0.00% ✗ -
Dec 15, 2016 Dec 20, 2016 KRIEGSMAN STEVEN A CEO Neutral 90.0 +2,325,581 100.00% ✗ -
Dec 15, 2016 Dec 19, 2016 LEVITT DANIEL J EVP and Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Dec 15, 2016 Dec 19, 2016 Wieland Douglas Scott Sr VP - Drug Development Neutral 52.5 - 0.00% ✗ -
Dec 15, 2016 Dec 19, 2016 CALOZ JOHN Y CFO Neutral 52.5 - 0.00% ✗ -
Dec 15, 2016 Dec 19, 2016 KRIEGSMAN STEVEN A CEO Neutral 52.5 - 0.00% ✗ -
Dec 15, 2016 Dec 19, 2016 RUBINFELD JOSEPH Director Neutral 52.5 - 0.00% ✗ -
Dec 15, 2016 Dec 19, 2016 IGNARRO LOUIS Director Neutral 52.5 - 0.00% ✗ -
Dec 15, 2016 Dec 19, 2016 Chawla Anita J Director Neutral 52.5 - 0.00% ✗ -
Dec 15, 2016 Dec 19, 2016 Brien Earl W Director Neutral 52.5 - 0.00% ✗ -
Dec 9, 2016 Brien Earl W Director Neutral 52.5 - 0.00% ✗ -
Dec 2, 2016 Dec 6, 2016 Brien Earl W Director Neutral 52.5 - 0.00% ✗ -
Dec 6, 2016 Brien Earl W Director Neutral 52.5 - 0.00% ✗ -
Jan 11, 2016 Jan 14, 2016 Ware Olivia C Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Jan 14, 2016 Ware Olivia C Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Dec 15, 2015 Dec 17, 2015 Wieland Douglas Scott Sr VP - Drug Development Neutral 52.5 - 0.00% ✗ -
Dec 15, 2015 Dec 17, 2015 SELTER ERIC JAY Director Neutral 52.5 - 0.00% ✗ -
Dec 15, 2015 Dec 17, 2015 RUBINFELD JOSEPH Director Neutral 52.5 - 0.00% ✗ -
Dec 15, 2015 Dec 17, 2015 Levin Ben SVP-Legal Affairs/GC/Secy Neutral 52.5 - 0.00% ✗ -
Dec 15, 2015 Dec 17, 2015 IGNARRO LOUIS Director Neutral 52.5 - 0.00% ✗ -
Dec 15, 2015 Dec 17, 2015 Cohen Cheryl Director Neutral 52.5 - 0.00% ✗ -
Dec 15, 2015 Dec 17, 2015 Chawla Anita J Director Neutral 52.5 - 0.00% ✗ -
Dec 15, 2015 Dec 17, 2015 CALOZ JOHN Y CFO Neutral 52.5 - 0.00% ✗ -
Dec 15, 2015 Dec 17, 2015 LEVITT DANIEL J EVP and Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Dec 15, 2015 Dec 17, 2015 KRIEGSMAN STEVEN A CEO Neutral 52.5 - 0.00% ✗ -
Jun 25, 2015 Cohen Cheryl Director Neutral 52.5 - 0.00% ✗ -
May 4, 2015 SELTER ERIC JAY Director Neutral 52.5 - 0.00% ✗ -
Mar 11, 2015 Chawla Anita J Director Neutral 52.5 - 0.00% ✗ -
Dec 15, 2014 Dec 17, 2014 CALOZ JOHN Y CFO Neutral 52.5 - 0.00% ✗ -
Dec 15, 2014 Dec 17, 2014 LEVITT DANIEL J EVP and Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Dec 15, 2014 Dec 17, 2014 Wieland Douglas Scott Sr VP - Drug Development Neutral 52.5 - 0.00% ✗ -
Dec 15, 2014 Dec 17, 2014 Levin Ben GC/SVP-Legal Affairs/Secy Neutral 52.5 - 0.00% ✗ -
Dec 15, 2014 Dec 16, 2014 KRIEGSMAN STEVEN A CEO Neutral 52.5 - 0.00% ✗ -
Dec 15, 2014 Dec 16, 2014 RUBINFELD JOSEPH Director Neutral 52.5 - 0.00% ✗ -
Dec 15, 2014 Dec 16, 2014 IGNARRO LOUIS Director Neutral 52.5 - 0.00% ✗ -
Dec 15, 2015 Dec 16, 2014 Wennekamp Richard L. Director Neutral 52.5 - 0.00% ✗ -
Dec 15, 2014 Dec 16, 2014 RUBINFELD JOSEPH Director Neutral 52.5 - 0.00% ✗ -
Dec 15, 2014 Dec 16, 2014 IGNARRO LOUIS Director Neutral 52.5 - 0.00% ✗ -
Jan 1, 2014 Jan 28, 2014 LEVITT DANIEL J EVP and Chief Medical Officer Neutral 90.0 +100,000 163.84% ✗ -
Jan 1, 2014 Jan 10, 2014 LEVITT DANIEL J EVP and Chief Medical Officer Neutral 90.0 +100,000 172.46% ✗ -
Jan 1, 2014 Jan 3, 2014 LEVITT DANIEL J EVP and Chief Medical Officer Neutral 90.0 +100,000 173.29% ✗ -
Jan 1, 2014 Jan 3, 2014 LEVITT DANIEL J EVP and Chief Medical Officer Neutral 90.0 +100,000 87.50% ✗ -
Dec 10, 2013 Dec 12, 2013 SELTER MARVIN R Director Neutral 52.5 - 0.00% ✗ -
Dec 10, 2013 Dec 12, 2013 LEVITT DANIEL J EVP and Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Dec 10, 2013 Dec 12, 2013 Levin Ben GC/SVP Legal Affairs/Secy Neutral 52.5 - 0.00% ✗ -
Dec 10, 2013 Dec 12, 2013 Wennekamp Richard L. Director Neutral 52.5 - 0.00% ✗ -
Dec 10, 2013 Dec 12, 2013 RUBINFELD JOSEPH Director Neutral 52.5 - 0.00% ✗ -
Dec 10, 2013 Dec 12, 2013 LINK MAX Director Neutral 52.5 - 0.00% ✗ -
Dec 10, 2013 Dec 12, 2013 IGNARRO LOUIS Director Neutral 52.5 - 0.00% ✗ -
Dec 10, 2013 Dec 12, 2013 Patterson Scott Bradford 10% Owner Sell 20.0 -334,979 -6.82% ✗ $805.3K
Dec 10, 2013 Dec 11, 2013 KRIEGSMAN STEVEN A CEO Neutral 52.5 - 0.00% ✗ -
Dec 10, 2013 Dec 11, 2013 Wieland Douglas Scott Sr. VP - Drug Development Neutral 52.5 - 0.00% ✗ -
Dec 10, 2013 Dec 11, 2013 CALOZ JOHN Y CFO Neutral 52.5 - 0.00% ✗ -
Nov 29, 2013 Dec 3, 2013 Patterson Scott Bradford 10% Owner Buy 92.5 +284,979 6.16% ✗ $694.5K
Nov 7, 2013 Nov 8, 2013 Patterson Scott Bradford 10% Owner Buy 82.5 +50,000 1.09% ✗ $102.8K
Apr 1, 2013 Apr 3, 2013 Patterson Scott Bradford 10% Owner Buy 56.3 +4,083 0.09% ✗ $11K
Mar 20, 2013 Mar 22, 2013 Patterson Scott Bradford 10% Owner Buy 56.3 +3,980 0.09% ✗ $10.4K
Mar 18, 2013 Mar 20, 2013 Patterson Scott Bradford 10% Owner Buy 72.5 +35,520 0.78% ✗ $91.5K
Mar 11, 2013 Mar 14, 2013 Patterson Scott Bradford 10% Owner Buy 82.5 +55,360 1.24% ✗ $147.6K
Mar 8, 2013 Mar 12, 2013 KRIEGSMAN STEVEN A CEO Neutral 52.5 - 0.00% ✗ -
Dec 31, 2012 Jan 7, 2013 LEVITT DANIEL J EVP & Chief Medical Officer Neutral 90.0 +100,000 699.99% ✗ -
Dec 31, 2012 Jan 2, 2013 LEVITT DANIEL J Chief Medical Officer Neutral 90.0 +100,000 100.00% ✗ -
Dec 10, 2012 Dec 11, 2012 SELTER MARVIN R Director Neutral 52.5 - 0.00% ✗ -
Dec 10, 2012 Dec 11, 2012 SELTER MARVIN R Director Neutral 52.5 - 0.00% ✗ -
Dec 10, 2012 Dec 11, 2012 RUBINFELD JOSEPH Director Neutral 52.5 - 0.00% ✗ -
Dec 10, 2012 Dec 11, 2012 IGNARRO LOUIS Director Neutral 52.5 - 0.00% ✗ -
Dec 10, 2012 Dec 11, 2012 Wennekamp Richard L. Director Neutral 52.5 - 0.00% ✗ -
Dec 10, 2012 Dec 11, 2012 LINK MAX Director Neutral 52.5 - 0.00% ✗ -
Dec 10, 2012 Dec 11, 2012 CALOZ JOHN Y CFO Neutral 52.5 - 0.00% ✗ -
Dec 10, 2012 Dec 11, 2012 Wieland Douglas Scott Sr. VP - Drug Development Neutral 52.5 - 0.00% ✗ -